2017 annual financial data
REGENXBIO 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was -557.99%.
Operating income was -75,885,000 USD and net income was -73,169,000 USD.
Operating cash flow was -57,992,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,393,000 USD
- Operating income
- -75,885,000 USD
- Net income
- -73,169,000 USD
- Operating cash flow
- -57,992,000 USD